Biomarkers for Drug Discovery & Development | Whitepapers & Reports

Development and Validation of Five Idiopathic Pulmonary Fibrosis (IPF) Biomarker Panels Comprising 12 Immunoassays: Advancing Clinical Diagnostic, Pharmacodynamic and Disease Activity Assessments in IPF